Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
